This suggests that in the setting of NSCLC with aberrant KEAP1-NRF2 pathway, increased SLC7A11 expression might empower tumors to evade CD8-IFNγ-induced ferroptosis. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.